Download presentation
Published byMadeline Ritchie Modified over 11 years ago
1
Chronic Renal Failure in Cats: Can we Halt the Decline?
Martha Cannon BA VetMB DSAM(Fel) RCVS Specialist in Feline Medicine Oxford Cat Clinic
2
Chronic Kidney Disease
3
Chronic Kidney Disease
Consequences of Kidney Disease Polyuria / polydipsia dehydration Nausea vomiting / inappetence Renal secondary hyperparathyroidism ( Phos) Proteinuria Hypertension Hypokalaemia Urinary tract infections Anaemia
4
IRIS Staging System Creatinine Serum Phosphate Proteinuria Blood Pressure
5
CRF: IRIS Staging System
Creatinine: After treating dehydration Stage 1: Non-azotaemic > 33% nephrons Stage 2: Creat 140 – 250 33-25% nephrons Stage 3: Creat 251 – 439 25-10% nephrons Stage 4: Creat > 440 <10% nephrons
6
Aims of Treatment Stage 2: Creatinine 140-250 μmol/l
Aim: (Reverse the cause) Prevent progression (Serum phosphate, urine protein and UTI’s, blood pressure) Stage 3: Creatinine μmol/l Aim: Prevent progression and manage azotaemia to improve quality of life Stage 4: Creatinine >440 μmol/l Treatment mostly aimed at managing azotaemia
7
IRIS Staging System Creatinine Serum Phosphate Proteinuria Blood Pressure
8
Recommended levels are well within laboratory reference ranges
Hyperphosphataemia IRIS recommendations: Stage I + II: mmol/l Stage III: mmol/l Stage IV: mmol/l Recommended levels are well within laboratory reference ranges
9
Hyperphosphataemia Reduced phosphate diet is most effective treatment
Additional advantages of prescription diets Reduced azotaemia, K+ supplement, Vit B supplement, soluble fibre, ? Omega-3 FAs
10
Hyperphosphataemia Protein Restricted Diet Reduces uraemia
Improves well-being, appetite, activity Reduces dietary phosphate intake Controls hyperphosphataemia Prolongs life-span Median 800 days vs 264 days
11
Hyperphosphataemia Reduced phosphate diet is most effective way to control phosphate Additional advantages of prescription diets Reduced azotaemia, K+ supplement, Vit B supplement, Soluble fibre, Omega-3 FAs
12
Chronic Kidney Disease
Nutritional Management Ensure adequate intake Delay introduction until cat feels well Learned food aversion Canned diets Energy from fat cf carbohydrate Increased fluid intake
13
Phosphate Binders Hyperphosphataemia despite dietary control
Allow 6-8 weeks for control of phosphate Gradual introduction of binder if phosphate remains high
14
Hyperphosphataemia Intestinal Phosphate Binders
~10% reduction in serum phosphate Give mixed with food Divide between all meals Introduce gradually and titrate to effect Monitor serum calcium when introducing binders
15
IRIS Staging System Creatinine Serum Phosphate Proteinuria Blood Pressure
16
IRIS Staging System Rule out UTI / FLUTD
Must check urine sediment or culture Asymptomatic bacterial urinary infections are common in cats with CKD, especially female cats
17
IRIS Staging System Proteinuria with no active sediment
UP:C > 0.4 = proteinuric Treat with an ACE inhibitor UP:C < 0.2 = non-proteinuric No treatment required UP:C =borderline Monitor / treat
18
Chronic Renal Failure Urinary Tract Infections Asymptomatic UTI’s
Female cats Low urine SG ? Occult pyelonephritis Risk of ascending infection renal damage
19
Chronic Renal Failure Urinary Tract Infections Treatment
4-6 weeks of antibiotic Bactericidal antibiotic Repeat urine sediment +/- culture Before end of antibiotics 10 days after ceasing antibiotics
20
IRIS Staging System Creatinine Serum Phosphate Proteinuria Blood Pressure
21
CRF: IRIS Staging System
Hypertension Common consequence of CRF Contributes to progression of CRF
22
CRF: IRIS Staging System
Blood Pressure “Risk of end organ damage” < 150 mmHg = Minimal risk mmHg = Low risk mmHg = Moderate risk > 180 mmHg = High risk
23
CRF: Blood Pressure For cats with CRF Maintain BP below 170 mmHg
Amlodipine: – 1.25 mg per cat per day 1/8 or 1/4 of a tablet once daily Adjunctive Treatment Benazepril
24
Chronic Renal Failure in Cats: Can we Halt the Decline?
Martha Cannon BA VetMB DSAM(Fel) RCVS Specialist in Feline Medicine Oxford Cat Clinic
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.